Cargando…
Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
Heparin‐induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed wit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693689/ https://www.ncbi.nlm.nih.gov/pubmed/26732728 http://dx.doi.org/10.1002/ccr3.411 |